{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:05:31Z","timestamp":1779426331036,"version":"3.53.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00259-026-07784-8","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:17:45Z","timestamp":1771024665000},"page":"4348-4359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current and future perspectives of molecular breast imaging with [99mTc]Tc-Sestamibi: An IAEA international expert panel"],"prefix":"10.1007","volume":"53","author":[{"given":"Angela","family":"Collarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-5065","authenticated-orcid":false,"given":"Giusi","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie B.","family":"Hruska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Garganese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Florit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaiane M.","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giammarile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato A.","family":"Vald\u00e9s Olmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Di Giuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka M.","family":"Pereira Arias-Bouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"7784_CR1","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1148\/radiol.14141233","volume":"273","author":"BN Joe","year":"2014","unstructured":"Joe BN, Sickles EA. The evolution of breast imaging: past to present. Radiology. 2014;273:S23\u201344. https:\/\/doi.org\/10.1148\/radiol.14141233.","journal-title":"Radiology"},{"key":"7784_CR2","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/BF01084367","volume":"23","author":"L Mansi","year":"1996","unstructured":"Mansi L, Rambaldi PF, Procaccini E, Gregorio FD, Laprovitera A, Pecori B, et al. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur J Nucl Med. 1996;23:932\u20139. https:\/\/doi.org\/10.1007\/BF01084367.","journal-title":"Eur J Nucl Med"},{"key":"7784_CR3","first-page":"1233","volume":"40","author":"I Khalkhali","year":"1999","unstructured":"Khalkhali I, Diggles LE, Taillefer R, Vandestreek PR, Peller PJ, Abdel-Nabi HH. Procedure guideline for breast scintigraphy. J Nucl Med. 1999;40:1233\u20135.","journal-title":"J Nucl Med"},{"key":"7784_CR4","doi-asserted-by":"publisher","first-page":"BP107","DOI":"10.1007\/s00259-003-1354-3","volume":"30","author":"E Bombardieri","year":"2003","unstructured":"Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, et al. Breast scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003;30:BP107\u2013114. https:\/\/doi.org\/10.1007\/s00259-003-1354-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7784_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00259-012-2279-5","volume":"40","author":"Y Sun","year":"2013","unstructured":"Sun Y, Wei W, Yang H-W, Liu J-L. Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2013;40:450\u201363. https:\/\/doi.org\/10.1007\/s00259-012-2279-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7784_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.ro.2021.12.006","volume":"57","author":"CB Hruska","year":"2022","unstructured":"Hruska CB. Updates in molecular breast imaging. Semin Roentgenol. 2022;57:134\u20138. https:\/\/doi.org\/10.1053\/j.ro.2021.12.006.","journal-title":"Semin Roentgenol"},{"key":"7784_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/j.semnuclmed.2004.11.002","volume":"35","author":"R Taillefer","year":"2005","unstructured":"Taillefer R. Clinical applications of 99mTc-sestamibi scintimammography. Semin Nucl Med. 2005;35:100\u201315. https:\/\/doi.org\/10.1053\/j.semnuclmed.2004.11.002.","journal-title":"Semin Nucl Med"},{"key":"7784_CR8","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.2967\/jnumed.115.159202","volume":"57","author":"RL Wahl","year":"2016","unstructured":"Wahl RL. Quo vadis: PET and single-photon molecular breast imaging. J Nucl Med. 2016;57:3S-8S. https:\/\/doi.org\/10.2967\/jnumed.115.159202.","journal-title":"J Nucl Med"},{"key":"7784_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1148\/radiol.2019182947","volume":"292","author":"RM Mann","year":"2019","unstructured":"Mann RM, Cho N, Moy L. Breast MRI: state of the art. Radiology. 2019;292:520\u201336. https:\/\/doi.org\/10.1148\/radiol.2019182947.","journal-title":"Radiology"},{"key":"7784_CR10","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.21037\/tcr-2025-485","volume":"14","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhang D, Wang X-N, Chen Y-N, Pan M-F, Guerrini S, et al. Diagnostic test of conventional ultrasonography combined with contrast-enhanced ultrasound in the subcategorization of suspicious Breast Imaging-Reporting and Data System (BI-RADS) 4 breast lesions. Transl Cancer Res. 2025;14:2066\u201377. https:\/\/doi.org\/10.21037\/tcr-2025-485.","journal-title":"Transl Cancer Res"},{"key":"7784_CR11","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1007\/s00259-024-06694-x","volume":"51","author":"D Groheux","year":"2024","unstructured":"Groheux D, Vaz SC, Ulaner GA, Cook GJR, Woll JPP, Mann RM, et al. Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET\/CT in no special type breast cancer: differences and agreements with European and American guidelines. Eur J Nucl Med Mol Imaging. 2024;51:2701\u20135. https:\/\/doi.org\/10.1007\/s00259-024-06694-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7784_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.cpet.2023.05.001","volume":"18","author":"SR O\u2019Brien","year":"2023","unstructured":"O\u2019Brien SR, Ward R, Wu GG, Bagheri S, Kiani M, Challa A, et al. Other novel PET radiotracers for breast cancer. PET Clin. 2023;18:557\u201366. https:\/\/doi.org\/10.1016\/j.cpet.2023.05.001.","journal-title":"PET Clin"},{"key":"7784_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2967\/jnumed.123.265420","volume":"64","author":"GA Ulaner","year":"2023","unstructured":"Ulaner GA, Mankoff DA, Clark AS, Fowler AM, Linden HM, Peterson LM, et al. Summary: appropriate use criteria for estrogen receptor-targeted PET imaging with 16\u03b1-18F-fluoro-17\u03b2-fluoroestradiol. J Nucl Med. 2023;64:351\u20134. https:\/\/doi.org\/10.2967\/jnumed.123.265420.","journal-title":"J Nucl Med"},{"key":"7784_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2967\/jnumed.121.261988","volume":"63","author":"MF Covington","year":"2022","unstructured":"Covington MF, Parent EE, Dibble EH, Rauch GM, Fowler AM. Advances and future directions in molecular breast imaging. J Nucl Med. 2022;63:17\u201321. https:\/\/doi.org\/10.2967\/jnumed.121.261988.","journal-title":"J Nucl Med"},{"key":"7784_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2967\/jnumed.113.126102","volume":"55","author":"AM Fowler","year":"2014","unstructured":"Fowler AM. A molecular approach to breast imaging. J Nucl Med. 2014;55:177\u201380. https:\/\/doi.org\/10.2967\/jnumed.113.126102.","journal-title":"J Nucl Med"},{"key":"7784_CR16","doi-asserted-by":"publisher","DOI":"10.1118\/1.4802733","volume":"40","author":"CB Hruska","year":"2013","unstructured":"Hruska CB, O\u2019Connor MK. Nuclear imaging of the breast: translating achievements in instrumentation into clinical use. Med Phys. 2013;40:050901. https:\/\/doi.org\/10.1118\/1.4802733.","journal-title":"Med Phys"},{"key":"7784_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2214\/AJR.19.22622","volume":"215","author":"EH Dibble","year":"2020","unstructured":"Dibble EH, Hunt KN, Ehman EC, O\u2019Connor MK. Molecular Breast Imaging in Clinical Practice. AJR Am J Roentgenol. 2020;215:277\u201384. https:\/\/doi.org\/10.2214\/AJR.19.22622.","journal-title":"AJR Am J Roentgenol"},{"key":"7784_CR18","first-page":"1646","volume":"31","author":"ML Chiu","year":"1990","unstructured":"Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med. 1990;31:1646\u201353.","journal-title":"J Nucl Med"},{"key":"7784_CR19","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s00259-005-1840-x","volume":"32","author":"J-L Moretti","year":"2005","unstructured":"Moretti J-L, Hauet N, Caglar M, Rebillard O, Burak Z. To use MIBI or not to use MIBI? That is the question when assessing tumour cells. Eur J Nucl Med Mol Imaging. 2005;32:836\u201342. https:\/\/doi.org\/10.1007\/s00259-005-1840-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7784_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00259-004-1530-0","volume":"31","author":"S Del Vecchio","year":"2004","unstructured":"Del Vecchio S, Salvatore M. 99mTc-MIBI in the evaluation of breast cancer biology. Eur J Nucl Med Mol Imaging. 2004;31:88\u201396. https:\/\/doi.org\/10.1007\/s00259-004-1530-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7784_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2967\/jnumed.124.268967","volume":"66","author":"L Urso","year":"2025","unstructured":"Urso L, Uccelli L, Boschi A, Schillaci O, Filippi L. Molecular imaging in cancer chemoresistance: what\u2019s brewing? J Nucl Med. 2025;66:344\u20138. https:\/\/doi.org\/10.2967\/jnumed.124.268967.","journal-title":"J Nucl Med"},{"key":"7784_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48\u201358. https:\/\/doi.org\/10.1038\/nrc706.","journal-title":"Nat Rev Cancer"},{"key":"7784_CR23","first-page":"977","volume":"53","author":"D Piwnica-Worms","year":"1993","unstructured":"Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 1993;53:977\u201384.","journal-title":"Cancer Res"},{"key":"7784_CR24","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00259-011-2054-z","volume":"39","author":"AL Conners","year":"2012","unstructured":"Conners AL, Hruska CB, Tortorelli CL, Maxwell RW, Rhodes DJ, Boughey JC, et al. Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2012;39:971\u201382. https:\/\/doi.org\/10.1007\/s00259-011-2054-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7784_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2967\/jnmt.121.264204","volume":"50","author":"CB Hruska","year":"2022","unstructured":"Hruska CB, Corion C, de Geus-Oei L-F, Adrada BE, Fowler AM, Hunt KN, et al. SNMMI procedure standard\/EANM practice guideline for molecular breast imaging with dedicated \u03b3-cameras. J Nucl Med Technol. 2022;50:103\u201310. https:\/\/doi.org\/10.2967\/jnmt.121.264204.","journal-title":"J Nucl Med Technol"},{"key":"7784_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2967\/jnmt.125.270865","volume":"53","author":"EH Dibble","year":"2025","unstructured":"Dibble EH, Vaz SC, Arun B, Fowler AM, de Geus-Oei L-F, Hunt KN, et al. Appropriate use criteria for molecular breast imaging. J Nucl Med Technol. 2025;53:287\u201397. https:\/\/doi.org\/10.2967\/jnmt.125.270865.","journal-title":"J Nucl Med Technol"},{"key":"7784_CR27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/RLU.0000000000005851","volume":"50","author":"SC Vaz","year":"2025","unstructured":"Vaz SC, Corion CLS, Goeman J, Zeillemaker AM, Hezemans R, de Geus-Oei L-F, et al. Can molecular breast imaging with Tc-99m sestamibi safely rule out malignancy in pathologic nipple discharge? Clin Nucl Med. 2025;50:568\u201376. https:\/\/doi.org\/10.1097\/RLU.0000000000005851.","journal-title":"Clin Nucl Med"},{"key":"7784_CR28","first-page":"92","volume":"2","author":"DL Wahner-Roedler","year":"2011","unstructured":"Wahner-Roedler DL, Hruska CB, O\u2019Connor MK, Phillips SW, Whaley DH, Johnson RE, et al. Molecular breast imaging for women presenting with a history of non-reproducible bloody nipple discharge and negative findings on routine imaging studies: a pilot study. J Surg Radiol. 2011;2:92\u20139.","journal-title":"J Surg Radiol"},{"key":"7784_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1148\/radiol.2019190887","volume":"293","author":"JH Sumkin","year":"2019","unstructured":"Sumkin JH, Berg WA, Carter GJ, Bandos AI, Chough DM, Ganott MA, et al. Diagnostic performance of MRI, molecular breast imaging, and contrast-enhanced mammography in women with newly diagnosed breast cancer. Radiology. 2019;293:531\u201340. https:\/\/doi.org\/10.1148\/radiol.2019190887.","journal-title":"Radiology"},{"key":"7784_CR30","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1007\/s00330-022-08617-6","volume":"32","author":"RM Mann","year":"2022","unstructured":"Mann RM, Athanasiou A, Baltzer PAT, Camps-Herrero J, Clauser P, Fallenberg EM, et al. Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol. 2022;32:4036\u201345. https:\/\/doi.org\/10.1007\/s00330-022-08617-6.","journal-title":"Eur Radiol"},{"key":"7784_CR31","doi-asserted-by":"publisher","first-page":"W267","DOI":"10.2214\/AJR.17.19355","volume":"211","author":"V Sorin","year":"2018","unstructured":"Sorin V, Yagil Y, Yosepovich A, Shalmon A, Gotlieb M, Neiman OH, et al. Contrast-Enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. AJR Am J Roentgenol. 2018;211:W267\u201374. https:\/\/doi.org\/10.2214\/AJR.17.19355.","journal-title":"AJR Am J Roentgenol"},{"key":"7784_CR32","doi-asserted-by":"publisher","DOI":"10.21037\/tbcr-24-64","volume":"6","author":"DU Tari","year":"2025","unstructured":"Tari DU, Santarsiere M, De Lucia DR, Santonastaso R. Contrast-enhanced mammography in high-dense breasts: a narrative review. Transl Breast Cancer Res. 2025;6:15. https:\/\/doi.org\/10.21037\/tbcr-24-64.","journal-title":"Transl Breast Cancer Res"},{"key":"7784_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2214\/AJR.14.13357","volume":"204","author":"DJ Rhodes","year":"2015","unstructured":"Rhodes DJ, Hruska CB, Conners AL, Tortorelli CL, Maxwell RW, Jones KN, et al. Molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. AJR Am J Roentgenol. 2015;204:241\u201351. https:\/\/doi.org\/10.2214\/AJR.14.13357.","journal-title":"AJR Am J Roentgenol"},{"key":"7784_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2214\/AJR.15.15924","volume":"207","author":"RB Shermis","year":"2016","unstructured":"Shermis RB, Wilson KD, Doyle MT, Martin TS, Merryman D, Kudrolli H, et al. Supplemental breast cancer screening with molecular breast imaging for women with dense breast tissue. AJR Am J Roentgenol. 2016;207:450\u20137. https:\/\/doi.org\/10.2214\/AJR.15.15924.","journal-title":"AJR Am J Roentgenol"},{"key":"7784_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1148\/radiol.10100570","volume":"257","author":"RE Hendrick","year":"2010","unstructured":"Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology. 2010;257:246\u201353. https:\/\/doi.org\/10.1148\/radiol.10100570.","journal-title":"Radiology"},{"key":"7784_CR36","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.243953","volume":"316","author":"CB Hruska","year":"2025","unstructured":"Hruska CB, Hunt KN, Larson NB, Miller PA, Ellis RL, Shermis RB, et al. Molecular breast imaging and digital breast tomosynthesis for dense breast screening: the density MATTERS trial. Radiology. 2025;316:e243953. https:\/\/doi.org\/10.1148\/radiol.243953.","journal-title":"Radiology"},{"key":"7784_CR37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.amjsurg.2008.06.005","volume":"196","author":"CB Hruska","year":"2008","unstructured":"Hruska CB, Boughey JC, Phillips SW, Rhodes DJ, Wahner-Roedler DL, Whaley DH, et al. Molecular breast imaging: A review of the Mayo clinic experience. Am J Surg. 2008;196:470\u20136. https:\/\/doi.org\/10.1016\/j.amjsurg.2008.06.005.","journal-title":"Am J Surg"},{"key":"7784_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10549-014-2920-z","volume":"145","author":"HS Lee","year":"2014","unstructured":"Lee HS, Ko BS, Ahn SH, Son BH, Lee JW, Kim HJ, et al. Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat. 2014;145:91\u2013100. https:\/\/doi.org\/10.1007\/s10549-014-2920-z.","journal-title":"Breast Cancer Res Treat"},{"key":"7784_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10549-018-4706-1","volume":"169","author":"A Collarino","year":"2018","unstructured":"Collarino A, Vald\u00e9s Olmos RA, van Berkel LGAJ, Neijenhuis PA, Wijers LMH, Smit F, et al. The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery. Breast Cancer Res Treat. 2018;169:513\u201322. https:\/\/doi.org\/10.1007\/s10549-018-4706-1.","journal-title":"Breast Cancer Res Treat"},{"key":"7784_CR40","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2214\/AJR.18.20628","volume":"213","author":"KN Hunt","year":"2019","unstructured":"Hunt KN, Conners AL, Goetz MP, O\u2019Connor MK, Suman V, Kalari K, et al. Comparison of 99mTc-Sestamibi molecular breast imaging and breast MRI in patients with invasive breast cancer receiving neoadjuvant chemotherapy. AJR Am J Roentgenol. 2019;213:932\u201343. https:\/\/doi.org\/10.2214\/AJR.18.20628.","journal-title":"AJR Am J Roentgenol"},{"key":"7784_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clbc.2017.06.008","volume":"18","author":"A Collarino","year":"2018","unstructured":"Collarino A, de Koster EJ, Vald\u00e9s Olmos RA, de Geus-Oei L-F, Pereira Arias-Bouda LM. Is technetium-99m sestamibi imaging able to predict pathologic nonresponse to neoadjuvant chemotherapy in breast cancer? A meta-analysis evaluating current use and shortcomings. Clin Breast Cancer. 2018;18:9\u201318. https:\/\/doi.org\/10.1016\/j.clbc.2017.06.008.","journal-title":"Clin Breast Cancer"},{"key":"7784_CR42","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s11307-024-01959-1","volume":"26","author":"A van de Burgt","year":"2024","unstructured":"van de Burgt A, van Velden FHP, Corion CLS, Collarino A, Olmos RAV, Smit F, et al. Comparison between prone SPECT-based semi-quantitative parameters and MBI-based semi-quantitative parameters in patients with locally advanced breast cancer. Mol Imaging Biol. 2024;26:926\u201333. https:\/\/doi.org\/10.1007\/s11307-024-01959-1.","journal-title":"Mol Imaging Biol"},{"key":"7784_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s40336-016-0201-z","volume":"4","author":"A Collarino","year":"2016","unstructured":"Collarino A, Vald\u00e9s Olmos RA, van der Hoeven AF, Pereira Arias-Bouda LM. Methodological aspects of 99mTc-sestamibi guided biopsy in breast cancer. Clin Transl Imaging. 2016;4:367\u201376. https:\/\/doi.org\/10.1007\/s40336-016-0201-z.","journal-title":"Clin Transl Imaging"},{"key":"7784_CR44","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2214\/AJR.17.18083","volume":"209","author":"A Collarino","year":"2017","unstructured":"Collarino A, Olmos RAV, Neijenhuis PA, den Hartog WC, Smit F, de Geus-Oei L-F, et al. First clinical experience using stereotactic breast biopsy guided by 99mTc-Sestamibi. AJR Am J Roentgenol. 2017;209:1367\u201373. https:\/\/doi.org\/10.2214\/AJR.17.18083.","journal-title":"AJR Am J Roentgenol"},{"key":"7784_CR45","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.230186","volume":"6","author":"KN Hunt","year":"2024","unstructured":"Hunt KN, Conners AL, Gray L, Hruska CB, O\u2019Connor MK. Molecular breast imaging biopsy with a dual-detector system. Radiol Imaging Cancer. 2024;6:e230186. https:\/\/doi.org\/10.1148\/rycan.230186.","journal-title":"Radiol Imaging Cancer"},{"key":"7784_CR46","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2214\/AJR.20.23854","volume":"216","author":"CB Hruska","year":"2021","unstructured":"Hruska CB, Geske JR, Conners AL, Whaley DH, Rhodes DJ, O\u2019Connor MK, et al. Background parenchymal uptake on molecular breast imaging and breast cancer risk: A cohort study. AJR Am J Roentgenol. 2021;216:1193\u2013204. https:\/\/doi.org\/10.2214\/AJR.20.23854.","journal-title":"AJR Am J Roentgenol"},{"key":"7784_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2214\/AJR.19.21582","volume":"214","author":"AT Tao","year":"2020","unstructured":"Tao AT, Hruska CB, Conners AL, Hunt KN, Swanson TN, Tran TD, et al. Dose reduction in molecular breast imaging with a new image-processing algorithm. AJR Am J Roentgenol. 2020;214:185\u201393. https:\/\/doi.org\/10.2214\/AJR.19.21582.","journal-title":"AJR Am J Roentgenol"},{"key":"7784_CR48","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2214\/ajr.174.6.1741779","volume":"174","author":"AJ Klaus","year":"2000","unstructured":"Klaus AJ, Klingensmith WC, Parker SH, Stavros AT, Sutherland JD, Aldrete KD. Comparative value of 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses. AJR Am J Roentgenol. 2000;174:1779\u201383. https:\/\/doi.org\/10.2214\/ajr.174.6.1741779.","journal-title":"AJR Am J Roentgenol"},{"key":"7784_CR49","first-page":"882","volume":"43","author":"T Massardo","year":"2002","unstructured":"Massardo T, Alonso O, Kabasakal L, Llamas-Olier A, Shankar UR, Zhu H, et al. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions. J Nucl Med. 2002;43:882\u20138.","journal-title":"J Nucl Med"},{"key":"7784_CR50","first-page":"1822","volume":"45","author":"R Tiling","year":"2004","unstructured":"Tiling R, Stephan K, Sommer H, Shabani N, Linke R, Hahn K. Tissue-specific effects on uptake of 99mTc-sestamibi by breast lesions: a targeted analysis of false scintigraphic diagnoses. J Nucl Med. 2004;45:1822\u20138.","journal-title":"J Nucl Med"},{"key":"7784_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1148\/radiol.2461061298","volume":"246","author":"NHGM Peters","year":"2008","unstructured":"Peters NHGM, Borel Rinkes IHM, Zuithoff NPA, Mali WPTM, Moons KGM, Peeters PHM. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008;246:116\u201324. https:\/\/doi.org\/10.1148\/radiol.2461061298.","journal-title":"Radiology"},{"key":"7784_CR52","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1148\/radiol.211412","volume":"302","author":"A Cozzi","year":"2022","unstructured":"Cozzi A, Magni V, Zanardo M, Schiaffino S, Sardanelli F. Contrast-enhanced mammography: a systematic review and meta-analysis of diagnostic performance. Radiology. 2022;302:568\u201381. https:\/\/doi.org\/10.1148\/radiol.211412.","journal-title":"Radiology"},{"key":"7784_CR53","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1016\/j.crad.2024.01.035","volume":"79","author":"E Giannotti","year":"2024","unstructured":"Giannotti E, Van Nijnatten TJA, Chen Y, Bicchierai G, Nori J, De Benedetto D, et al. The role of contrast-enhanced mammography in the preoperative evaluation of invasive lobular carcinoma of the breast. Clin Radiol. 2024;79:e799\u2013806. https:\/\/doi.org\/10.1016\/j.crad.2024.01.035.","journal-title":"Clin Radiol"},{"key":"7784_CR54","first-page":"1973","volume":"41","author":"I Khalkhali","year":"2000","unstructured":"Khalkhali I, Villanueva-Meyer J, Edell SL, Connolly JL, Schnitt SJ, Baum JK, et al. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med. 2000;41:1973\u20139.","journal-title":"J Nucl Med"},{"key":"7784_CR55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1148\/radiol.2473061678","volume":"247","author":"RF Brem","year":"2008","unstructured":"Brem RF, Floerke AC, Rapelyea JA, Teal C, Kelly T, Mathur V. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology. 2008;247:651\u20137. https:\/\/doi.org\/10.1148\/radiol.2473061678.","journal-title":"Radiology"},{"key":"7784_CR56","doi-asserted-by":"publisher","first-page":"W374","DOI":"10.2214\/AJR.14.13502","volume":"205","author":"AL Conners","year":"2015","unstructured":"Conners AL, Jones KN, Hruska CB, Geske JR, Boughey JC, Rhodes DJ. Direct-conversion molecular breast imaging of invasive breast cancer: imaging features, extent of invasive disease, and comparison between invasive ductal and lobular histology. AJR Am J Roentgenol. 2015;205:W374-81. https:\/\/doi.org\/10.2214\/AJR.14.13502.","journal-title":"AJR Am J Roentgenol"},{"key":"7784_CR57","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1002\/mp.16213","volume":"50","author":"BP Lopez","year":"2023","unstructured":"Lopez BP, Kappadath SC. Monte Carlo-derived 99m Tc uptake quantification with commercial planar MBI: tumor and breast activity concentrations. Med Phys. 2023;50:4388\u201398. https:\/\/doi.org\/10.1002\/mp.16213.","journal-title":"Med Phys"},{"key":"7784_CR58","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/153473540200100302","volume":"1","author":"RM Fleming","year":"2002","unstructured":"Fleming RM. Mitochondrial uptake of Sestamibi distinguishes between normal, inflammatory breast changes, pre-cancers, and infiltrating breast cancer. Integr Cancer Ther. 2002;1:229\u201337. https:\/\/doi.org\/10.1177\/153473540200100302.","journal-title":"Integr Cancer Ther"},{"key":"7784_CR59","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","volume":"18","author":"N Avril","year":"2000","unstructured":"Avril N, Ros\u00e9 CA, Schelling M, Dose J, Kuhn W, Bense S, et al. Breast imaging with positron emission tomography and Fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol. 2000;18:3495\u2013502. https:\/\/doi.org\/10.1200\/JCO.2000.18.20.3495.","journal-title":"J Clin Oncol"},{"key":"7784_CR60","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12149-011-0556-1","volume":"26","author":"BS Kim","year":"2012","unstructured":"Kim BS, Sung SH. Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer. Ann Nucl Med. 2012;26:175\u201383. https:\/\/doi.org\/10.1007\/s12149-011-0556-1.","journal-title":"Ann Nucl Med"},{"key":"7784_CR61","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s00259-003-1132-2","volume":"30","author":"R Danielsson","year":"2003","unstructured":"Danielsson R, S\u00e1nchez-Crespo A, Pegerfalk A, Grabowska H, Larsson SA, Bon\u00e9 B, et al. 99mTc-sestamibi uptake and histological malignancy grade in invasive breast carcinoma. Eur J Nucl Med Mol Imaging. 2003;30:662\u20136. https:\/\/doi.org\/10.1007\/s00259-003-1132-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7784_CR62","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.breast.2006.12.009","volume":"16","author":"LL Travaini","year":"2007","unstructured":"Travaini LL, Baio SM, Cremonesi M, De Cicco C, Ferrari M, Trifir\u00f2 G, et al. Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response. Breast. 2007;16:262\u201370. https:\/\/doi.org\/10.1016\/j.breast.2006.12.009.","journal-title":"Breast"},{"key":"7784_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1102\/1470-7330.2011.0001","volume":"11","author":"S Dizdarevic","year":"2011","unstructured":"Dizdarevic S, Peters AM. Imaging of multidrug resistance in cancer. Cancer Imaging. 2011;11:1\u20138. https:\/\/doi.org\/10.1102\/1470-7330.2011.0001.","journal-title":"Cancer Imaging"},{"key":"7784_CR64","doi-asserted-by":"publisher","first-page":"S295","DOI":"10.21037\/tcr.2017.10.28","volume":"7","author":"A Collarino","year":"2018","unstructured":"Collarino A, Fuoco V, Arias-Bouda LMP, S\u00e1nchez AM, Geus-Oei L-Fde, Masetti R, et al. Novel frontiers of dedicated molecular imaging in breast cancer diagnosis. Transl Cancer Res. 2018;7:S295\u2013306. https:\/\/doi.org\/10.21037\/tcr.2017.10.28.","journal-title":"Transl Cancer Res"},{"key":"7784_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57469-3","volume":"16","author":"Y-W Chang","year":"2025","unstructured":"Chang Y-W, Ryu JK, An JK, Choi N, Park YM, Ko KH, et al. Artificial intelligence for breast cancer screening in mammography (AI-STREAM): preliminary analysis of a prospective multicenter cohort study. Nat Commun. 2025;16:2248. https:\/\/doi.org\/10.1038\/s41467-025-57469-3.","journal-title":"Nat Commun"},{"key":"7784_CR66","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1475-097X.2008.00801.x","volume":"28","author":"T Bach-Gansmo","year":"2008","unstructured":"Bach-Gansmo T, Bogsrud TV, Skretting A. Integrin scintimammography using a dedicated breast imaging, solid-state gamma-camera and (99m)Tc-labelled NC100692. Clin Physiol Funct Imaging. 2008;28:235\u20139. https:\/\/doi.org\/10.1111\/j.1475-097X.2008.00801.x.","journal-title":"Clin Physiol Funct Imaging"},{"key":"7784_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-017-0255-6","volume":"7","author":"MK O\u2019Connor","year":"2017","unstructured":"O\u2019Connor MK, Morrow MMB, Hunt KN, Boughey JC, Wahner-Roedler DL, Conners AL, et al. Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer. EJNMMI Res. 2017;7:5. https:\/\/doi.org\/10.1186\/s13550-017-0255-6.","journal-title":"EJNMMI Res"},{"key":"7784_CR68","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.apradiso.2008.01.012","volume":"66","author":"H Kurihara","year":"2008","unstructured":"Kurihara H, Yang DJ, Cristofanilli M, Erwin WD, Yu D-F, Kohanim S, et al. Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors. Appl Radiat Isot. 2008;66:1175\u201382. https:\/\/doi.org\/10.1016\/j.apradiso.2008.01.012.","journal-title":"Appl Radiat Isot"},{"key":"7784_CR69","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1177\/030089160208800331","volume":"88","author":"F Scopinaro","year":"2002","unstructured":"Scopinaro F, Varvarigou A, Ussof W, De Vincentis G, Archimandritis S, Evangelatos G, et al. Breast cancer takes up 99mTc bombesin. A preliminary report. Tumori. 2002;88:S25\u20138. https:\/\/doi.org\/10.1177\/030089160208800331.","journal-title":"Tumori"},{"key":"7784_CR70","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1148\/radiol.2203001639","volume":"220","author":"RJ Bennink","year":"2001","unstructured":"Bennink RJ, Rijks LJ, van Tienhoven G, Noorduyn LA, Janssen AG, Sloof GW. Estrogen receptor status in primary breast cancer: iodine 123-labeled cis-11beta-methoxy-17alpha-iodovinyl estradiol scintigraphy. Radiology. 2001;220:774\u20139. https:\/\/doi.org\/10.1148\/radiol.2203001639.","journal-title":"Radiology"},{"key":"7784_CR71","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1021\/acs.molpharmaceut.1c00569","volume":"18","author":"L Zhao","year":"2021","unstructured":"Zhao L, Liu C, Xing Y, He J, O\u2019Doherty J, Huang W, et al. Development of a 99mTc-labeled single-domain antibody for SPECT\/CT assessment of HER2 expression in breast cancer. Mol Pharm. 2021;18:3616\u201322. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00569.","journal-title":"Mol Pharm"},{"key":"7784_CR72","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.7150\/thno.86770","volume":"13","author":"O Bragina","year":"2023","unstructured":"Bragina O, Chernov V, Larkina M, Rybina A, Zelchan R, Garbukov E, et al. Phase i clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer. Theranostics. 2023;13:4858\u201371. https:\/\/doi.org\/10.7150\/thno.86770.","journal-title":"Theranostics"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07784-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07784-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07784-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:10:23Z","timestamp":1779423023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07784-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7784"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07784-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the Patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"AMF receives book chapter royalty from Elsevier, Inc. The other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}